Earnings History Data for Sage Therapeutics, Inc. (SAGE) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Sage Therapeutics, Inc.

SAGE Therapeutics Inc. is a biopharmaceutical company developing and commercializing medicines to treat life-threatening central nervous system (CNS) disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Its initial product candidates include SAGE-547, SAGE-689 and SAGE-217. SAGE Therapeutics, Inc. is based in Cambridge, Massachusetts.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-02-2024	PM		SAGE	Sage Therapeutics, Inc.	1,430	-0.55	-1.17	-2.47	Sage Therapeutics GAAP EPS of -$0.55 beats by $0.76, revenue of $77.97M beats by $16.99M [2/14/2024 6:33 AM]	25.75	2.73 (11.86%)	25.24	2.22 (9.64%)	16.51 - 59.99	2,429,946	910,000	7,702
Sage Therapeutics Q4 2023 Earnings Preview [2/13/2024 11:09 AM] Sage Therapeutics GAAP EPS of -$0.55 beats by $0.76, revenue of $77.97M beats by $16.99M [2/14/2024 6:33 AM]
07-11-2023	PM		SAGE	Sage Therapeutics, Inc.	1,270	-2.81	-2.64	-2.31	Sage Therapeutics GAAP EPS of -$3.37 misses by $0.67, revenue of $2.72M misses by $0.45M [11/7/2023 6:32 AM]	19.59	-1.02 (-4.95%)	18.07	-2.54 (-12.32%)	16.51 - 59.99	1,279,919	980,000	1,872
Sage Therapeutics Q3 2023 Earnings Preview [11/6/2023 3:12 PM] Sage Therapeutics GAAP EPS of -$3.37 misses by $0.67, revenue of $2.72M misses by $0.45M [11/7/2023 6:32 AM] Sage Therapeutics falls after stock offering, Q3 miss [11/7/2023 8:30 AM]
07-08-2023	PM		SAGE	Sage Therapeutics	2,152	-2.68	-2.53	0.00	Sage Therapeutics GAAP EPS of -$2.68 misses by $0.11, revenue of $2.47M misses by $0.44M [8/7/2023 6:30 AM]	16.63	-19.47 (-53.93%)	18.75	-17.35 (-48.06%)	16.51 - 59.99	16,154,908	1,890,000	2,675,046
Sage Therapeutics GAAP EPS of -$2.68 misses by $0.11, revenue of $2.47M misses by $0.44M [8/7/2023 6:30 AM] Sage, Biogen zuranolone OKd for postpartum, but not major, depression [8/4/2023 7:53 PM] Sage plummets 46% after FDA declines zuranolone in major depression [8/7/2023 7:39 AM] Biggest stock movers today: Tyson Food, Sovos Brands, Yellow Corporation and more [8/7/2023 10:00 AM]
02-05-2023	PM	6:30 AM ET (May 2)	SAGE	Sage Therapeutics, Inc.	2,830	-2.46	-2.50	-2.07	Sage Therapeutics GAAP EPS of -$2.46 beats by $0.06, revenue of $3.3M beats by $1.02M [5/2/2023 6:38 AM]	45.58	-3.06 (-6.29%)	0.0	0.0 (0.00%)	27.36 - 50.16	610,447	540,000	0
Sage Therapeutics Q1 2023 Earnings Preview [5/1/2023 1:08 PM] Sage Therapeutics GAAP EPS of -$2.46 beats by $0.06, revenue of $3.3M beats by $1.02M [5/2/2023 6:38 AM]
16-02-2023	PM	6:30 AM ET (Feb 16)	SAGE	Sage Therapeutics, Inc.	2,670	-2.47	-2.37	-2.12		45.05	-0.06 (-0.13%)	45.11	0.0 (0.00%)	27.36 - 49.56	468,525	430,000	21,730
Sage Therapeutics mixed Q4 earnings; initiates FY23 outlook [2/16/2023 6:35 AM]
08-11-2022	PM	6:30 AM ET (Nov 8)	SAGE	Sage Therapeutics, Inc.	2,180	-2.31	-2.16	-2.21	Sage Therapeutics GAAP EPS of -$2.31 misses by $0.11, revenue of $1.74M beats by $0.08M [11/8/2022 6:33 AM]	33.97	0.09 (0.27%)	33.88	0.0 (0.00%)	27.36 - 45.74	568,643	410,000	12,915
Sage Therapeutics GAAP EPS of -$2.31 misses by $0.11, revenue of $1.74M beats by $0.08M [11/8/2022 6:33 AM]
02-08-2022	PM	6:30 AM ET (Aug 2)	SAGE	Sage Therapeutics, Inc.	2,050	-2.13	-2.16	-1.83	Sage Therapeutics GAAP EPS of -$2.13 beats by $0.02, revenue of $1.5M misses by $0.27M [8/2/2022 6:40 AM]	35.29	0.84 (2.44%)	34.45	0.0 (0.00%)	27.36 - 47.75	362,172	470,000	29,390
Sage Therapeutics Q2 2022 Earnings Preview [8/1/2022 1:09 PM] Sage Therapeutics GAAP EPS of -$2.13 beats by $0.02, revenue of $1.5M misses by $0.27M [8/2/2022 6:40 AM] Sage Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Pipeline and Business Progress [Aug-02-22 06:30AM] Sage Therapeutics to Present at Upcoming August Investor Conferences [Aug-01-22 06:30AM]
03-05-2022	PM	6:30 AM ET (May 3)	SAGE	Sage Therapeutics	1,915	-2.07	-2.09	0.00	Sage Therapeutics GAAP EPS of -$2.07 misses by $0.04, revenue of $1.58M misses by $1.65M [5/3/2022 6:37 AM]	32.87	0.27 (0.83%)	32.60	0.0 (0.00%)	30.48 - 80.23	349,065	550,000	26,847
Sage Therapeutics Q1 2022 Earnings Preview [5/2/2022 11:30 AM] Sage, Biogen begin rolling submission with FDA for zuranolone to treat depression [5/2/2022 7:18 AM] Sage Therapeutics GAAP EPS of -$2.07 misses by $0.04, revenue of $1.58M misses by $1.65M [5/3/2022 6:37 AM] 10 Market-Moving Stocks to Watch on Monday [May-02-22 03:44PM] Sage Therapeutics, Biogen Start Rolling Submission For Zuranolone In Major Depressive Disorder [May-02-22 12:58PM] Sage, Biogen start 'rolling submission' to FDA for depression drug [May-02-22 07:52AM] Sage Therapeutics and Biogen Initiate Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for Zuranolone for the Potential Treatment of Major Depressive Disorder (MDD) [May-02-22 06:30AM] Sage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Lags Revenue Estimates [May-03-22 07:55AM] Sage Therapeutics Announces First Quarter 2022 Financial Results and Highlights Pipeline and Business Progress [May-03-22 06:30AM]
24-02-2022	PM	6:30 AM ET (Feb 24)	SAGE	Sage Therapeutics, Inc.	2,010	-2.12	-2.16	-2.47	Sage Therapeutics GAAP EPS of -$2.12 beats by $0.05, revenue of $1.6M misses by $0.17M [2/24/2022 6:32 AM]	32.61	-1.43 (0.00%)	0.0	0.0 (0.00%)	32.60 - 88.51	690,198	566,288	0
Sage Therapeutics Q4 2021 Earnings Preview [2/23/2022 1:15 PM] Sage Therapeutics GAAP EPS of -$2.12 beats by $0.05, revenue of $1.6M misses by $0.17M [2/24/2022 6:32 AM] Biotech Stock Roundup: SAGE, ATRA Down on Study Updates, AGIO Drug Approval & More [Feb-23-22 12:57PM] Sage Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Highlights Pipeline and Business Progress [Feb-24-22 06:30AM] Sage Therapeutics, Inc. (SAGE) Reports Q4 Loss, Misses Revenue Estimates [Feb-24-22 07:45AM] The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Sage Therapeutics, Biogen Agios Pharmaceuticals Atara Biotherapeutics [Feb-24-22 12:03PM]
02-11-2021	PM	6:30 AM ET (Nov 2)	SAGE	Sage Therapeutics, Inc.	2,420	-2.21	-1.84	-2.03	Sage Therapeutics EPS misses by $0.36, misses on revenue [11/2/2021 6:36 AM]	43.57	1.20 (2.83%)	43.57	0.0 (0.00%)	39.12 - 98.39	1,412,711	590,000	7,179
Sage Therapeutics Q3 2021 Earnings Preview [11/1/2021 12:56 PM] Sage Therapeutics EPS misses by $0.36, misses on revenue [11/2/2021 6:36 AM] Sage Therapeutics posts Q3 earnings miss, pipeline update [11/2/2021 6:58 AM] Sage stock hits 52-week low as departure of medical chief follows earnings miss [11/2/2021 10:30 AM] Should You Buy Sage Therapeutics (SAGE) Ahead of Earnings? [Nov-01-21 10:50AM] Sage Therapeutics Announces Third Quarter 2021 Financial Results and Highlights Pipeline and Business Progress [Nov-02-21 06:30AM] Sage Therapeutics, Inc. (SAGE) Reports Q3 Loss, Lags Revenue Estimates [Nov-02-21 07:45AM] Sage Therapeutics Inc (SAGE) Q3 2021 Earnings Call Transcript [Nov-02-21 02:00PM]
03-08-2021	PM	6:30 AM ET (Aug 3)	SAGE	Sage Therapeutics, Inc.	2,560	-1.83	-1.69	-2.08	Sage Therapeutics EPS misses by $0.15, misses on revenue [8/3/2021 6:37 AM]	41.71	-1.66 (-3.84%)	44.00	0.63 (1.45%)	40.82 - 98.39	1,311,940	820,000	2,533
Sage Therapeutics Q2 2021 Earnings Preview [8/2/2021 1:33 PM] Sage Therapeutics EPS misses by $0.15, misses on revenue [8/3/2021 6:37 AM] Sage Therapeutics shares rise on narrower Q2 net loss, cash position update [8/3/2021 7:45 AM] Sage Therapeutics Announces Second Quarter 2021 Financial Results and Highlights Pipeline and Business Progress [Aug-03-21 06:30AM] Sage Therapeutics, Inc. (SAGE) Reports Q2 Loss, Lags Revenue Estimates [Aug-03-21 07:55AM] Sage Therapeutics Inc (SAGE) Q2 2021 Earnings Call Transcript [Aug-03-21 04:00PM]
04-05-2021	PM	6:30 AM ET (May 4)	SAGE	Sage Therapeutics, Inc.	4,460	-1.64	-1.98	-2.44	Sage Therapeutics EPS beats by $0.31, misses on revenue [5/4/2021 6:37 AM]	71.14	-7.82 (-9.90%)	78.96	0.0 (0.00%)	33.82 - 98.39	990,725	440,000	7,078
Sage Therapeutics EPS beats by $0.31, misses on revenue [5/4/2021 6:37 AM] Sage Therapeutics Announces First Quarter 2021 Financial Results and Highlights Pipeline and Business Progress [May-04-21 06:30AM] Sage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Misses Revenue Estimates [May-04-21 07:45AM]
24-02-2021	PM	6:30 AM ET (Feb 24)	SAGE	Sage Therapeutics, Inc.	4,800	-2.47	-2.17	-3.25	Sage Therapeutics EPS of $18.19 [2/24/2021 6:36 AM]	84.97	4.73 (5.89%)	79.05	-1.19 (-1.48%)	25.01 - 98.38	487,841	385,205	5,150
Sage Therapeutics EPS of $18.19 [2/24/2021 6:36 AM] Sage Therapeutics Q4 2020 Earnings Preview [2/23/2021 11:21 AM] Sage Therapeutics Rises After Swing to Profit on Biogen Deal [Feb-24-21 06:53AM]
05-11-2020	PM	6:30 AM ET (Nov 5)	SAGE	Sage Therapeutics, Inc.	3,860	-2.03	-2.30	-3.48	Sage Therapeutics EPS beats by $0.34, misses on revenue [11/5/2020 6:36 AM]	78.11	-0.44 (-0.56%)	78.11	0.0 (0.00%)	25.01 - 155.33	573,374	528,017	5,069

10-08-2020	PM	4:00 PM ET (Aug 10)	SAGE	Sage Therapeutics, Inc.	2,600	-2.08	-2.67	-3.28	Sage Therapeutics EPS beats by $0.06, beats on revenue [8/10/2020 6:33 AM]	51.39	0.69 (1.36%)	51.20	0.50 (0.99%)	25.01 - 173.76	596,505	641,408	610